Open AccessSystematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Invasive Pneumococcal Disease Among Young Children
Author(s) -
Laura Conklin,
Jennifer D. Loo,
Jennifer Kirk,
Katherine E. Fleming-Dutra,
Maria Deloria Knoll,
Daniel E. Park,
David Green,
Katherine L. O’Brien,
Cynthia G. Whitney
Publication year - 2014
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000000078
Subject(s) - medicine , pneumococcal conjugate vaccine , observational study , dosing , booster (rocketry) , pneumococcal disease , pediatrics , booster dose , clinical trial , randomized controlled trial , immunization , streptococcus pneumoniae , immunology , antigen , physics , astronomy , biology , genetics , bacteria
Pneumococcal conjugate vaccines (PCV) are being implemented globally using a variety of different schedules. The optimal schedule to maximize protection of vaccinated children against vaccine-type invasive pneumococcal disease (VT-IPD) is not known.